Found: 46
Select item for more details and to access through your institution.
Corticosteroids compromise survival in glioblastoma.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Alkylpurine-DNA-N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.
- Published in:
- 2012
- By:
- Publication type:
- journal article
Alkylpurine--DNA--N-glycosylase confers resistance to temozolomide in xenograft models of glioblastoma multiforme and is associated with poor survival in patients.
- Published in:
- Journal of Clinical Investigation, 2012, v. 122, n. 1, p. 253, doi. 10.1172/JCI59334
- By:
- Publication type:
- Article
Measuring change in health-related quality of life: the impact of different analytical methods on the interpretation of treatment effects in glioma patients.
- Published in:
- Neuro-Oncology Practice, 2020, v. 7, n. 6, p. 668, doi. 10.1093/nop/npaa033
- By:
- Publication type:
- Article
Methylome analyses of three glioblastoma cohorts reveal chemotherapy sensitivity markers within DDR genes.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 22, p. 8373, doi. 10.1002/cam4.3447
- By:
- Publication type:
- Article
Chromosome 1p loss evaluation in anaplastic oligodendrogliomas.
- Published in:
- Neuropathology, 2008, v. 28, n. 4, p. 440, doi. 10.1111/j.1440-1789.2008.00863.x
- By:
- Publication type:
- Article
Memory in low-grade glioma patients treated with radiotherapy or temozolomide: a correlative analysis of EORTC study 22033-26033.
- Published in:
- Neuro-Oncology, 2021, v. 23, n. 5, p. 803, doi. 10.1093/neuonc/noaa252
- By:
- Publication type:
- Article
Validation of diffusion MRI phenotypes for predicting response to bevacizumab in recurrent glioblastoma: post-hoc analysis of the EORTC-26101 trial.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 11, p. 1667, doi. 10.1093/neuonc/noaa120
- By:
- Publication type:
- Article
Temporal muscle thickness is an independent prognostic marker in patients with progressive glioblastoma: translational imaging analysis of the EORTC 26101 trial.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 12, p. 1587, doi. 10.1093/neuonc/noz131
- By:
- Publication type:
- Article
Symptom clusters in newly diagnosed glioma patients: which symptom clusters are independently associated with functioning and global health status?
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 11, p. 1447, doi. 10.1093/neuonc/noz118
- By:
- Publication type:
- Article
Defining EGFR amplification status for clinical trial inclusion.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 10, p. 1263, doi. 10.1093/neuonc/noz096
- By:
- Publication type:
- Article
The RANO Leptomeningeal Metastasis Group proposal to assess response to treatment: lack of feasibility and clinical utility and a revised proposal.
- Published in:
- Neuro-Oncology, 2019, v. 21, n. 5, p. 648, doi. 10.1093/neuonc/noz024
- By:
- Publication type:
- Article
RBTT-08. EORTC 1709/CCTG CE.8: A PHASE III TRIAL OF MARIZOMIB IN COMBINATION WITH STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY VERSUS STANDARD TEMOZOLOMIDE-BASED RADIOCHEMOTHERAPY ALONE IN PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi235, doi. 10.1093/neuonc/noy148.977
- By:
- Publication type:
- Article
QOLP-29. SYMPTOM CLUSTERS IN NEWLY DIAGNOSED GLIOMA PATIENTS: WHICH CLUSTERS ARE ASSOCIATED WITH FUNCTIONING AND GLOBAL HEALTH STATUS?
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi221, doi. 10.1093/neuonc/noy148.915
- By:
- Publication type:
- Article
ACTR-53. STEAM / EORTC 1608: STUDY OF TG02 IN ELDERLY NEWLY DIAGNOSED OR ADULT RELAPSED PATIENTS WITH ANAPLASTIC ASTROCYTOMA OR GLIOBLASTOMA - A PHASE 1B STUDY.
- Published in:
- Neuro-Oncology, 2018, v. 20, p. vi23, doi. 10.1093/neuonc/noy148.085
- By:
- Publication type:
- Article
Is more better? The impact of extended adjuvant temozolomide in newly diagnosed glioblastoma: a secondary analysis of EORTC and NRG Oncology/RTOG.
- Published in:
- Neuro-Oncology, 2017, v. 19, n. 8, p. 1119, doi. 10.1093/neuonc/nox025
- By:
- Publication type:
- Article
Molecular classification of anaplastic oligodendroglioma using next-generation sequencing: a report of the prospective randomized EORTC Brain Tumor Group 26951 phase III trial.
- Published in:
- Neuro-Oncology, 2016, v. 18, n. 3, p. 388, doi. 10.1093/neuonc/nov182
- By:
- Publication type:
- Article
Changes in the EGFR amplification and EGFRvIII expression between paired primary and recurrent glioblastomas.
- Published in:
- Neuro-Oncology, 2015, v. 17, n. 7, p. 935, doi. 10.1093/neuonc/nov013
- By:
- Publication type:
- Article
New validated prognostic models and prognostic calculators in patients with low-grade gliomas diagnosed by central pathology review: a pooled analysis of EORTC/RTOG/NCCTG phase III clinical trials.
- Published in:
- Neuro-Oncology, 2013, v. 15, n. 11, p. 1568, doi. 10.1093/neuonc/not117
- By:
- Publication type:
- Article
EORTC 26083 phase I/II trial of dasatinib in combination with CCNU in patients with recurrent glioblastoma.
- Published in:
- Neuro-Oncology, 2012, v. 14, n. 12, p. 1503, doi. 10.1093/neuonc/nos256
- By:
- Publication type:
- Article
Prolonged survival for patients with newly diagnosed, inoperable glioblastoma with 3-times daily ultrafractionated radiation therapy.
- Published in:
- Neuro-Oncology, 2010, v. 12, n. 6, p. 595, doi. 10.1093/neuonc/noq008
- By:
- Publication type:
- Article
Association of antidepressant drug use with outcome of patients with glioblastoma.
- Published in:
- International Journal of Cancer, 2023, v. 152, n. 7, p. 1348, doi. 10.1002/ijc.34344
- By:
- Publication type:
- Article
Cost-effectiveness of temozolomide for the treatment of newly diagnosed glioblastoma multiforme: a report from the EORTC 26981/22981 NCI-C CE3 Intergroup Study.
- Published in:
- 2008
- By:
- Publication type:
- journal article
Histopathologic assessment of hot‐spot microvessel density and vascular patterns in glioblastoma: Poor observer agreement limits clinical utility as prognostic factors: A translational research project of the European Organization for Research and Treatment of Cancer Rrain Tumor Group
- Published in:
- Cancer (0008543X), 2006, v. 107, n. 1, p. 162
- By:
- Publication type:
- Article
Prognostic value of Ki67 index in anaplastic oligodendroglial tumours - a translational study of the European Organization for Research and Treatment of Cancer Brain Tumor Group.
- Published in:
- Histopathology, 2012, v. 60, n. 6, p. 885, doi. 10.1111/j.1365-2559.2011.04134.x
- By:
- Publication type:
- Article
Cost effectiveness of paclitaxel/cisplatin compared with cyclophosphamide/cisplatin in the treatment of advanced ovarian cancer in Belgium.
- Published in:
- 2002
- By:
- Publication type:
- journal article
Anti-O6-Methylguanine-Methyltransferase (MGMT) Immunohistochemistry in Glioblastoma Multiforme: Observer Variability and Lack of Association with Patient Survival Impede Its Use as Clinical Biomarker.
- Published in:
- Brain Pathology, 2008, v. 18, n. 4, p. 520, doi. 10.1111/j.1750-3639.2008.00153.x
- By:
- Publication type:
- Article
Panel review of a set of anaplastic oligodendroglioma of EORTC trial 26951: interobserver variation, correlation with 1p/19q loss and clinical outcome.
- Published in:
- FASEB Journal, 2007, v. 21, n. 5, p. A26, doi. 10.1096/fasebj.21.5.a26
- By:
- Publication type:
- Article
Associations of levetiracetam use with the safety and tolerability profile of chemoradiotherapy for patients with newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac112
- By:
- Publication type:
- Article
Use of metformin and outcome of patients with newly diagnosed glioblastoma: Pooled analysis.
- Published in:
- International Journal of Cancer, 2020, v. 146, n. 3, p. 803, doi. 10.1002/ijc.32337
- By:
- Publication type:
- Article
Epigenetic landscape reorganisation and reactivation of embryonic development genes are associated with malignancy in IDH-mutant astrocytoma.
- Published in:
- Acta Neuropathologica, 2024, v. 148, n. 1, p. 1, doi. 10.1007/s00401-024-02811-0
- By:
- Publication type:
- Article
Independent prognostic impact of DNA methylation class and chromosome 1p loss in WHO grade 2 and 3 meningioma undergoing adjuvant high-dose radiotherapy: comprehensive molecular analysis of EORTC 22042–26042.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 6, p. 837, doi. 10.1007/s00401-023-02642-5
- By:
- Publication type:
- Article
Spatial immune profiling of glioblastoma identifies an inflammatory, perivascular phenotype associated with longer survival.
- Published in:
- Acta Neuropathologica, 2023, v. 146, n. 4, p. 647, doi. 10.1007/s00401-023-02617-6
- By:
- Publication type:
- Article
The DNA methylome of DDR genes and benefit from RT or TMZ in IDH mutant low-grade glioma treated in EORTC 22033.
- Published in:
- Acta Neuropathologica, 2018, v. 135, n. 4, p. 601, doi. 10.1007/s00401-018-1810-6
- By:
- Publication type:
- Article
Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial.
- Published in:
- Acta Neuropathologica, 2012, v. 123, n. 6, p. 841, doi. 10.1007/s00401-011-0938-4
- By:
- Publication type:
- Article
Alpha-internexin expression predicts outcome in anaplastic oligodendroglial tumors and may positively impact the efficacy of chemotherapy.
- Published in:
- Cancer (0008543X), 2011, v. 117, n. 13, p. 3014, doi. 10.1002/cncr.25827
- By:
- Publication type:
- Article
Do statins, ACE inhibitors or sartans improve outcome in primary glioblastoma?
- Published in:
- Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 163, doi. 10.1007/s11060-018-2786-8
- By:
- Publication type:
- Article
Genomic aberrations associated with outcome in anaplastic oligodendroglial tumors treated within the EORTC phase III trial 26951.
- Published in:
- Journal of Neuro-Oncology, 2011, v. 103, n. 2, p. 221, doi. 10.1007/s11060-010-0380-9
- By:
- Publication type:
- Article
No benefit from TMZ treatment in glioblastoma with truly unmethylated MGMT promoter: Reanalysis of the CE.6 and the pooled Nordic/NOA-08 trials in elderly glioblastoma patients.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 10, p. 1867, doi. 10.1093/neuonc/noae108
- By:
- Publication type:
- Article
Marizomib for patients with newly diagnosed glioblastoma: A randomized phase 3 trial.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 9, p. 1670, doi. 10.1093/neuonc/noae053
- By:
- Publication type:
- Article
3D volume growth rate evaluation in the EORTC-BTG-1320 clinical trial for recurrent WHO grade 2 and 3 meningiomas.
- Published in:
- Neuro-Oncology, 2024, v. 26, n. 7, p. 1302, doi. 10.1093/neuonc/noae037
- By:
- Publication type:
- Article
Mitotic count is prognostic in IDH mutant astrocytoma without homozygous deletion of CDKN2A/B. Results of consensus panel review of EORTC trial 26053 (CATNON) and EORTC trial 22033-26033.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1443, doi. 10.1093/neuonc/noac282
- By:
- Publication type:
- Article
Factors associated with health-related quality of life (HRQoL) deterioration in glioma patients during the progression-free survival period.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 12, p. 2159, doi. 10.1093/neuonc/noac097
- By:
- Publication type:
- Article
Prognostic significance of therapy-induced myelosuppression in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 9, p. 1533, doi. 10.1093/neuonc/noac070
- By:
- Publication type:
- Article
MGMT promoter methylation determined by the MGMT-STP27 algorithm is not predictive for outcome to temozolomide in IDH-mutant anaplastic astrocytomas.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 4, p. 665, doi. 10.1093/neuonc/noac014
- By:
- Publication type:
- Article
EGFRvIII transcriptome in glioblastoma: A meta-omics analysis.
- Published in:
- Neuro-Oncology, 2022, v. 24, n. 3, p. 429, doi. 10.1093/neuonc/noab231
- By:
- Publication type:
- Article